We rely on donations from people like you to fund our research programs.
AIDS Research Alliance is a 501(c)(3) non-profit organization, every gift, large or small, is tax-deductible and moves our research forward.
Please join us as we strive to realize an HIV-free generation. Please support our work. Thank you.

We won’t stop until we’ve eradicated HIV/AIDS

Join the Alliance!

Banner

Dr. David Hardy Joins ARA Board; Brings 30+ Years HIV Experience

Return to The Insider: News & Views

April 25 2013

Dr. David Hardy with ARA CEO Carolyn Carlburg

AIDS Research Alliance is pleased to announce the addition of a very experienced HIV researcher and physician to our Board of Directors. Dr. David Hardy, the Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center, and Professor of Medicine at the David Geffen School of Medicine at UCLA, has been a supporter of AIDS Research Alliance for many years. As a Board member, he will bring more than 30 years of HIV experience—first treating HIV-positive patients, and then researching the disease. Currently, Dr. Hardy performs clinical trials (phase II and III) of investigational antiretroviral agents for the treatment of HIV and, in addition, therapeutic vaccines for HIV.

Early in the AIDS epidemic, Dr. Hardy completed a fellowship in infectious diseases/clinical immunology at the UCLA School of Medicine, mentored by Michael Gottlieb, MD, also a long-time friend to ARA, as well as the physician who reported the first cases of AIDS. Later, Dr. Hardy completed post-doctoral training in HIV laboratory research with Irvin Chen, PhD at the UCLA School of Medicine.

“I am excited about becoming a member of the Board of Directors at AIDS Research Alliance,” said Dr. Hardy. “I am interested in the organization’s work on the HIV reservoirs, particularly its work on prostratin. The research community is focusing more time and resources on the reservoirs, and the possibility of eradicating them, which is what prostratin aims to do as part of a larger cure strategy.”

“Further,” he continued, “I hope that my background in infectious disease will be helpful to AIDS Research Alliance as it expands its mission to include a broad portfolio of infectious diseases.”

“We are honored to welcome Dr. Hardy, a medical professional with over three decades of HIV/AIDS experience and knowledge, to our Board,” said ARA CEO Carolyn Carlburg. “We look forward to working with him, and to leveraging his knowledge for maximum results.”

Dr. Hardy chairs the Education Committee of the American Academy of HIV Medicine (AAHIVM), and serves as editor-in-chief of their Fundamentals of HIV Medicine for the HIV Specialist. He also serves on the Board of Directors of the HIV Medical Association (HIVMA).

Meet the rest of ARA’s Board of Directors




Return to The Insider: News & Views

Partners & Sponsors